WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from Pat Fogarty, Vice President, Assistant General Counsel, and Director, Civil Justice Policy regarding today’s decision from the New Jersey Appellate Division’s decision to remand the McGinnis case for a new trial preceded by Rule 104 hearing on the 510(k) clearance evidence.
AdvaMed Applauds NJ Appellate Division for Reversing Trial Court Order Regarding FDA Evidence Admissibility
Press Release | March 2, 2021
Medical Device Industry Challenges Misleading Information Campaign About the Safety and Use of Ethylene Oxide in Georgia
Press Release | March 1, 2021
WASHINGTON, D.C. – The CEO of the world’s largest medical technology trade association (AdvaMed) and the CEO of Georgia Bio, a trade association representing life sciences companies in Georgia, have teamed up to challenge misleading information that has been propagated by the media about the safety and use of ethylene oxide (EtO) — a chemical which is used to sterilize 20 billion medical devices annually in the U.S. and for which there is no alternative.
Press Release | February 23, 2021
WASHINGTON, D.C. – AdvaMed Accel, the division within AdvaMed dedicated to addressing the unique needs of small and start-up medical technology manufacturers, announced that Todd M. Pope, President and CEO of WellAir, has been named chair of the Accel Board of Directors for a two-year term.
Webinar: Expanding the Promise of Digital Health Technologies in Health Care - Building on Recent Advances
March 10, 2021 |
The Coronavirus Disease 2019 (COVID-19) public health emergency has dramatically demonstrated the power of digital health technologies to transform the delivery of health care. Expanded telehealth... Read More
April 27, 2021 | Online
The Value Assessment Workshop is designed to help companies better assess the value of a medical technology for coverage and reimbursement planning using AdvaMed’s Value Framework. This workshop will... Read More
May 6, 2021 |
The Digital MedTech Conference gathers the digital health community for an exploration of the evolving digital medtech landscape and the trends impacting the industry.
May 10, 2021 to May 12, 2021| Online
Please join us virtually from May 10-12, 2021 for the 13th Annual FDA/AdvaMed Medical Device Statistics Issues Conference. This annual conference brings together leading authorities from FDA,... Read More
SALT LAKE CITY--(BUSINESS WIRE)--O2TODAY ("O2TODAY"), a mask company that develops, manufactures and commercializes face masks for medical and non-medical uses, and SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) (www.sintx.com), an original equipment manufacturer (OEM) of silicon nitride ceramics, announced today they have entered into a worldwide exclusive licensing agreement. O2TODAY expects to release their first consumer mask integrated with SINTX’s silicon nitride...
BOSTON, Jan. 20, 2021 -- Haemonetics Corporation (NYSE: HAE) ("Haemonetics"), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered into a definitive agreement to acquire privately-held Cardiva Medical, Inc., ("Cardiva") an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. Under the terms of the agreement, Haemonetics will acquire Cardiva for an...
SBA Announces Recipients of Tibbetts Awards for Demonstrating Significant Economic and Social Impact from R&D Funding
Washington, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Today, the U.S. Small Business Administration announced 38 companies, seven organizations and 14 individuals as the winners of the prestigious Tibbetts Award for their accomplishments in creating cutting-edge technologies. The Tibbetts Awards, named after Roland Tibbetts, the founder of the SBIR Program, honors these awardees for the exceptional successes they achieved through SBA’s Small Business Innovation Research (SBIR) and Small Business...
Ortho’s VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First Widely-Available, High-Volume Test to Receive FDA Emergency Use Authorization
Ortho’s VITROS® SARS-CoV-2 Antigen Test is the first high-volume COVID-19 antigen test to receive Food and Drug Administration (FDA) Emergency Use Authorization (EUA). With utility for mass-scale testing and same-day results for labs, Ortho’s latest COVID-19 solution can run up to 130 tests per hour. The test is run on Ortho’s high-volume VITROS® Systems, which are installed in over 5,600 laboratories around the world with 1,500 installed in the U.S. RARITAN, N.J. (January 12, 2021) – Ortho...
SCOTTSDALE, Ariz., -- Regenesis Biomedical, Inc., a medical device company focused on safe, non-drug, pain management, announced today that the Board of Directors has unanimously elected Mr. Tom Eisiminger, Jr., as the next President and Chief Executive Officer (CEO), and member of the Board of Directors. Mr. Eisiminger succeeds Mr. Scott Brooks who recently retired. Scott Brooks' career spanned senior management positions in BSN medical, KCI, Hill-Rom Company and Kimberly-Clark Healthcare,...
March 5, 2021 - 11:29am
“AdvaMed agrees with Appellate Division that it is better to give jurors this information and trust them to get it… https://t.co/4t5biW5BXY